• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!

作者信息

Barac Aleksandra, Bartoletti Michele, Azap Ozlem, Bussini Linda, Ergonul Onder, Krause Robert, Paño-Pardo José Ramón, Power Nicholas R, Rodríguez-Baño Jesús, Sibani Marcella, Szabo Balint Gergely, Tsiodras Sotirios, Verweij Paul E, Quirós Alejandro Martín, Zollner-Schwetz Ines

机构信息

Clinic for Infectious and Tropical Diseases, Clinical Center of Serbia, Belgrade, Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.

出版信息

Clin Microbiol Infect. 2022 Jul;28(7):908-910. doi: 10.1016/j.cmi.2022.03.022. Epub 2022 Mar 23.

DOI:10.1016/j.cmi.2022.03.022
PMID:35337977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8942456/
Abstract
摘要

相似文献

1
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!在新冠疫情期间不适当使用伊维菌素：首要的是勿伤！
Clin Microbiol Infect. 2022 Jul;28(7):908-910. doi: 10.1016/j.cmi.2022.03.022. Epub 2022 Mar 23.
2
Potential therapeutic effects of Ivermectin in COVID-19.伊维菌素在 COVID-19 中的潜在治疗作用。
Exp Biol Med (Maywood). 2022 Aug;247(15):1388-1396. doi: 10.1177/15353702221099579. Epub 2022 Jun 10.
3
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验（SAINT）评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力：一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
4
Ivermectin: potential candidate for the treatment of Covid 19.伊维菌素：治疗新冠病毒病的潜在候选药物。
Braz J Infect Dis. 2020 Jul-Aug;24(4):369-371. doi: 10.1016/j.bjid.2020.06.002. Epub 2020 Jun 28.
5
Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2.非洲大规模药物管理与蠕虫防治经验：设想将伊维菌素用于治疗新型冠状病毒肺炎（SARS-CoV-2）
Am J Trop Med Hyg. 2020 Jul;103(1):10-11. doi: 10.4269/ajtmh.20-0295. Epub 2020 May 26.
6
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?羟氯喹啉和伊维菌素：用于新冠病毒化学预防和治疗的协同组合？
J Am Acad Dermatol. 2020 Jun;82(6):e221. doi: 10.1016/j.jaad.2020.04.017. Epub 2020 Apr 10.
7
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.伊维菌素的教训：仅基于汇总数据的荟萃分析本质上是不可靠的。
Nat Med. 2021 Nov;27(11):1853-1854. doi: 10.1038/s41591-021-01535-y.
8
Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.随机临床试验比较伊维菌素与安慰剂对秘鲁早期 COVID-19 患者鼻咽 PCR 转阴的疗效（SAINT-Peru）：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 9;22(1):262. doi: 10.1186/s13063-021-05236-2.
9
Ivermectin in COVID-19: What do we know?伊维菌素与新冠病毒：我们了解些什么？
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1921-1922. doi: 10.1016/j.dsx.2020.09.027. Epub 2020 Sep 28.
10
Antiviral and Anti-Inflammatory Properties of Ivermectin and Its Potential Use in COVID-19.伊维菌素的抗病毒和抗炎特性及其在COVID-19中的潜在用途
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):831. doi: 10.1016/j.arbres.2020.06.011. Epub 2020 Jul 7.

引用本文的文献

1
COVID-19 and a Tale of Three Drugs: To Repurpose, or Not to Repurpose-That Was the Question.新冠疫情与三种药物的故事：是否进行药物再利用——这就是问题所在。
Viruses. 2025 Jun 23;17(7):881. doi: 10.3390/v17070881.
2
Optimizing the Antimicrobial Effects by using Natural Compounds in COVID-19 Management.在新冠疫情管理中使用天然化合物优化抗菌效果。
Curr Med Chem. 2025;32(17):3329-3346. doi: 10.2174/0109298673294083240520044158.
3
Identification of side effects of COVID-19 drug candidates on embryogenesis using an integrated zebrafish screening platform.利用整合的斑马鱼筛选平台鉴定 COVID-19 候选药物对胚胎发生的副作用。
Sci Rep. 2023 Oct 9;13(1):17037. doi: 10.1038/s41598-023-43911-3.
4
Evolution of community health workers: the fourth stage.社区卫生工作者的演变：第四阶段。
Front Public Health. 2023 May 30;11:1209673. doi: 10.3389/fpubh.2023.1209673. eCollection 2023.